Healthcare provider profile · identity verified

Mobin Shah, MD

Internal Medicine · FAYETTEVILLE, GA · NPI 1932319613

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Quetiapine Fumarate	Quetiapine Fumarate	379	62
Furosemide	Furosemide	282	70
Amlodipine Besylate	Amlodipine Besylate	207	52
Potassium Chloride	Potassium Chloride	207	41
Levothyroxine Sodium	Levothyroxine Sodium	200	48
Sertraline Hcl	Sertraline Hcl	198	33
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	139	94
Escitalopram Oxalate	Escitalopram Oxalate	134	22
Mirtazapine	Mirtazapine	134	22
Pantoprazole Sodium	Pantoprazole Sodium	134	27
Divalproex Sodium	Divalproex Sodium	109	18
Tamsulosin Hcl	Tamsulosin Hcl	109	23
Cephalexin	Cephalexin	104	75
Gabapentin	Gabapentin	104	21
Citalopram Hbr	Citalopram Hydrobromide	91	25
Trazodone Hcl	Trazodone Hcl	87	25
Metoprolol Tartrate	Metoprolol Tartrate	83	22
Atorvastatin Calcium	Atorvastatin Calcium	74	17
Omeprazole	Omeprazole	74	19
Finasteride	Finasteride	71	12
Lisinopril	Lisinopril	71	18
Hydrochlorothiazide	Hydrochlorothiazide	69	11
Risperidone	Risperidone	62	11
Losartan Potassium	Losartan Potassium	61	14
Memantine Hcl	Memantine Hcl	61	25
Azithromycin	Azithromycin	59	44
Ropinirole Hcl	Ropinirole Hcl	59	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	58	12
Metoprolol Succinate	Metoprolol Succinate	57	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	32
Fluconazole	Fluconazole	52	33
Metformin Hcl	Metformin Hcl	50	14
Bupropion Xl	Bupropion Hcl	49	suppressed
Carvedilol	Carvedilol	47	suppressed
Famotidine	Famotidine	47	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	suppressed
Olanzapine	Olanzapine	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	44	11
Donepezil Hcl	Donepezil Hcl	43	15
Nitrofurantoin	Nitrofurantoin Macrocrystal	40	11
Duloxetine Hcl	Duloxetine Hcl	34	13
Atenolol	Atenolol	32	suppressed
Prednisone	Prednisone	31	13
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Eliquis	Apixaban	26	suppressed
Methylprednisolone	Methylprednisolone	26	22
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Digoxin	Digoxin	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Timolol Maleate	Timolol Maleate	23	suppressed
Glipizide	Glipizide	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	17
Doxycycline Hyclate	Doxycycline Hyclate	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Memantine Hcl Er	Memantine Hcl	19	suppressed
Temazepam	Temazepam	18	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Lorazepam	Lorazepam	15	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	11
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	11	suppressed
Colchicine	Colchicine	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error